Wednesday, March 19, 2008
 

 


Contact us:- Editor The Bottom Line

GlaxoSmithKline Asia Pacific Head to address CIMA CEO Forum


A senior regional representative of the global pharmaceuticals giant GlaxoSmithKline (GSK) will visit Sri Lanka later this month at the invitation of the Chartered Institute of Management Accountants (CIMA).

GSK’s Asia Pacific Senior Vice President and Regional Director V. Thyagarajan will be in Colombo to address the CIMA CEO Forum on March 25, 2008 at Cinnamon Grand Hotel.

Thyagarajan will speak on the theme “Globalisation and its impact on Asia” at the breakfast meeting of the forum, a spokesman for GSK in Sri Lanka announced.

Thyagarajan is responsible for GlaxoSmithKline operations in Asia Pacific and is based at the Company’s Headquarters in Singapore. Prior to his current position, he served as Vice President of South Asia since 2001. He has served on the Board of Glaxo India since 1992 and began his tenure as Managing Director in 1994. He is now the Vice Chairman of GlaxoSmithKline India.

A true veteran of GlaxoSmithKline, Thyagarajan has been with the company for close to 38 years. He began his career as a Management Trainee for Glaxo India in September 1970. He has held various increasingly senior positions throughout his career, including Marketing Consultant for Europe, Area Marketing Director for Middle East, Africa, and Eastern Europe as well as the Area Director for South East Asia, Bangladesh, Sri Lanka, and Taiwan.

Thyagarajan received a B. Tech (Elec) from the Indian Institute of Technology, Delhi and an M.B.A from the Indian Institute of Management, Ahmedabad. He is an independent director of Tata Consultancy Services Limited (India’s leading software company) and is on several advisory boards in India and Singapore. He was on the board of International Enterprises (I.E.) Singapore in 2007.

One of the world’s leading research-based pharmaceutical and healthcare companies, GlaxoSmithKline has been present in Sri Lanka for more than 50 years and is the country’s leading pharmaceuticals and vaccines company.